# Progress Note 03 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Phillis Wheatley (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EN015-SYN-TD
- Date: 1773-04-06
- Fictional facility: St. Posthumous Health Center
- Fictional author: Abena Hartley-Okonkwo, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Six-week asthma review and planning for a long sea journey. **S**

## History of present illness

Miss Wheatley returns six weeks after starting as-needed budesonide-formoterol. With the milder weather and the changes in the kitchen she is much better: she uses one inhalation two or three times a week, mostly before walking out in the wind, and has not woken at night for a month. Her two-week peak flow diary shows a best of 400 L/min. She has been invited abroad to see her book through the press and expects to sail in about a month, a long crossing followed by a summer in England, and she wants a plan in case her chest is bad at sea. She is prone to seasickness on short boat trips. **S**

| Element | Detail |
|---|---|
| Control | Asthma Control Test 21; reliever two or three times a week; no night waking for a month |
| Peak flow | Personal best 400 L/min |
| Upcoming | A long sea crossing in about a month and a summer abroad |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Respiratory | Negative | No night waking; slight wheeze in cold wind only |
| Ears, nose, mouth, and throat | Negative | No hoarseness or thrush |
| Gastrointestinal | Positive | Nausea on short boat trips in the past |
| Psychiatric | Negative | Looking forward to the journey, with some worry about falling ill far from help |

4 systems reviewed. **S**

## Current medications

- Budesonide-formoterol 160/4.5 mcg inhaler as needed only (GINA track 1, step 2, anti-inflammatory reliever): one inhalation whenever needed for symptoms or before exercise in the cold, no more than 12 inhalations a day **S**
- Prednisone 20 mg oral tablet, standby course for the sea journey and the summer away: two tablets (40 mg) each morning for five days, to start only as her action plan directs **S**
- Meclizine 25 mg oral tablet, one tablet an hour before sailing and then once daily as needed for seasickness **S**

## Allergies

- No known allergy **S**

## Objective

BP 104/64 mmHg; pulse 76 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 99% on room air; weight 46.4 kg; BMI 20.1 kg/m². All vital signs are synthetic.

Asthma Control Test: 21; Peak expiratory flow: 400 L/min. All results are synthetic.

## Change since baseline

- Asthma Control Test: 15 at baseline, 21 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well; weight 46.4 kg; oxygen saturation 99 percent; peak flow 395 L/min in clinic |
| Respiratory | Clear on forced expiration |
| Inhaler technique | Correct with the spacer, checked by teach-back |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Asthma, well controlled** (J45.30). Well controlled on as-needed budesonide-formoterol (Asthma Control Test 21), with no exacerbation. Step 2 is the right step; there is no reason to add maintenance treatment before the journey. Because she will be at sea for weeks, far from medical care, she needs enough medicine, a clear plan and a standby course. **S**
   - Two inhalers and the spacer in her cabin bag, more than enough for the summer.
   - Action plan updated with zones from her best of 400 L/min, and instructions for the standby course.
   - Standby prednisone 40 mg daily for five days, to start only if peak flow falls below 200 L/min, or below 320 L/min without improvement after 48 hours of extra reliever, and then to seek the ship's doctor or a local clinic.
   - Meclizine 25 mg for seasickness; avoid smoke-filled cabins and keep the cabin aired against damp.
   - Contact the clinic by message from abroad; printed medical summary.
2. **Prone to seasickness** (T75.3XXA). Likely at sea for a long crossing; meclizine is suitable and does not affect her asthma treatment. **S**
   - Meclizine 25 mg an hour before sailing and then once daily as needed; watch the horizon, stay on deck in fresh air when she can, and avoid reading in the first days at sea.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Asthma Control Test, symptoms, night waking and reliever use | Every visit | Completed today | Asthma Control Test 21; reliever two or three times a week; no night waking |
| Imaging | Peak flow personal best | After starting treatment, to set action plan zones | Completed today | Best 400 L/min from the diary; 395 in clinic |
| Examination | Inhaler technique with her own inhaler, and adherence | Every visit; before any step-up | Completed today | Correct with the spacer |
| Self-management | Written asthma action plan | Every visit and after every exacerbation | Completed today | Zones set from her best; travel instructions added |
| Self-management | Exacerbation history (oral corticosteroid courses, emergency visits, admissions) | Every visit | Completed today | None |
| Self-management | Step-up or step-down assessment (GINA track 1) | Every visit | Completed today | Controlled at step 2; no change |
| Self-management | Triggers, exposures and smoking or vaping | Every visit | Completed today | Window and fan when cooking; avoids fireplace smoke; scarf in the wind |
| Self-management | Travel planning | Before any long journey away from care | Completed today | Medicine supply, standby course, updated plan, medical summary and seasickness treatment |
| Imaging | Repeat spirometry | Three to six months after starting treatment | Due | After her return in the autumn |
| Self-management | Private conversation: consent, safety and exploitation, and her own decisions | Every visit | Completed today | Seen alone; she will travel as a member of a party from the household, and she alone decides on her own care abroad |

## Goal progress

- A confirmed diagnosis within two weeks: spirometry with bronchodilator response and FeNO, with tuberculosis excluded. Outcome by 1773-02-23: Asthma confirmed by a 330 mL (15 percent) bronchodilator response and FeNO 38 ppb; tuberculosis test negative and chest X-ray clear, two weeks after the first visit. **S**
- Asthma Control Test 20 or more with no night waking. Outcome by 1773-04-06: Asthma Control Test 21 and no night waking six weeks after starting treatment; 20 after the exacerbation. **S**
- Correct inhaler technique and a written action plan she can use at home and at sea. Outcome by 1773-04-06: Technique correct at every visit; plan used during the exacerbation. **S**
- Well enough to make the sea journey and spend the summer away. In progress; target 1773-09-21. **S**
- No exacerbation needing an oral corticosteroid. In progress; target 1773-10-26. **S**
- Hepatitis B and HPV vaccination complete. In progress; target 1774-01-25. **S**

## Medication changes

- Started: Prednisone 20 mg oral tablet, standby course for the sea journey and the summer away: two tablets (40 mg) each morning for five days, to start only as her action plan directs **S**
- Started: Meclizine 25 mg oral tablet, one tablet an hour before sailing and then once daily as needed for seasickness **S**

## Guideline basis

- CMID: Clinical Monitoring Intelligence Database, asthma monograph (2026), Aether Forge
- Global Strategy for Asthma Management and Prevention, 2025 update (2025), Global Initiative for Asthma
- 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group (2020), National Heart, Lung, and Blood Institute (J Allergy Clin Immunol 2020;146(6):1217-1270)
- Motion Sickness (CDC Yellow Book: Health Information for International Travel) (2026), Centers for Disease Control and Prevention

## Follow-up

- Preventive visit before she sails. Asthma review on her return in the autumn, sooner by message if needed. **S**
- Next scheduled visit 1773-04-27: periodic preventive visit before a long sea journey. **S**
